There is simply no other way to put this: Miebo is magic.
Dry eye disease (DED) and the space around it has been the “hot dot” in topical medical therapy in eye care for many years. Not since 2016 and Xiidra (lifitegrast ophthalmic solution 5%, Bausch + Lomb) have we had an FDA approval for a new compound or chemical to treat the signs, symptoms or both attributed to DED. This 7-year fallow period was preceded by an even longer 13-year drought that began with the approval and launch of (Read more...)